Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC 65219-594-20.
Published September 2, 2026 · Recall initiated: August 10, 2026
Summary
FDA records drug Class I recall D-0827-2026, published September 2, 2026 and initiated August 10, 2026. Recalling firm: Fresenius Kabi USA, LLC; Status: Ongoing; Reported quantity: 4,643 20mL-vials; Lot: Lot: 16UI07, Exp 08/31/2028. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email if TYENNE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TYENNE
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- Nationwide in the USA
- Lot
- Lot: 16UI07, Exp 08/31/2028
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPaxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: ApotexSeptember 2, 2026
- FDARamipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDCSeptember 2, 2026
- FDAActhar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARDSeptember 2, 2026
- FDALactated Ringer's Injection USP, 1000 mL EXCEL container, Rx only, L7500, B. Braun Medical, Inc., Bethlehem,September 2, 2026
- FDAZicam, Cold Remedy, Medicated Nasal Swabs, With Cooling Menthol & Eucalyptus, 20 Single-Use Swabs per carton,September 2, 2026
- FDASura Tanmen Hot and Sour Flavor Premium Japanese Noodles & Soup Base. Retail package net wt. 15.4oz. ProductSeptember 2, 2026
Questions about this recall
Was Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC 65219-594-20. recalled?
Yes. FDA published recall D-0827-2026 on September 2, 2026. Reported hazard: Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TYENNE.